Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2012 Results
Date:5/8/2012

The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers.  The access number is 20166070.

The conference call will be broadcast simultaneously on Vanda's website, http://www.vandapharma.com.  Investors should click on the Investor Relations tab and are advised to go to the website at least 15 minutes early to register, download, and install any necessary software or presentations.  The call will also be archived on Vanda's website for a period of 30 days, through June 6, 2012.

ABOUT VANDA PHARMACEUTICALS INC.:Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders.  For more on Vanda, please visit http://www.vandapharma.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Various statements in this release are "forward-looking statements" under the securities laws. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "project," "target," "goal," "likely," "will," "would," and "could," or the negative of these terms and similar expressions or words, identify forward-looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: the extent and effectiveness of the development, sales and marketing and distribution support Fanapt® receives; Vanda's ability to successfully commercialize Fanapt® outside of the U.S. and Canada; delays in the completion of Vanda's clinical trials; a failure of Vanda's products, product candidates or partnered products to be demonstrably safe
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 ExeGi Pharma, a company focused ... announced today that it has been granted a product ... Products Directorate (NNHPD) to sell Visbiome™ in ... by Professor Claudio De Simone , MD, PhD ... Professor De Simone recently signed an exclusive agreement with ...
(Date:7/1/2015)... 2015 According to a new ... Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), ... Global Forecast to 2020", published by MarketsandMarkets, the Transfection ... $957.9 Million by 2020 with a CAGR of 7.2% ... market T ables and 33 F ...
(Date:7/1/2015)... Mass. , July 1, 2015 Boston Scientific ... discussing financial results and business highlights for the second quarter ... 8 a.m. ET. The call will be hosted ... and Dan Brennan , executive vice president and chief ... call will be available via the Boston Scientific website. Webcast ...
Breaking Medicine Technology:ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2
(Date:7/1/2015)... ... 2015 , ... There is nothing new about marriage debates ... laws governing sexuality since the first Pilgrims landed at Plymouth Rock. The mid-1870s, ... Cindy Safronoff reveals. Crossing Swords: Mary Baker Eddy vs. Victoria Claflin Woodhull and ...
(Date:7/1/2015)... Lewisberry, PA (PRWEB) , ... July 01, 2015 ... ... their purist natural forms, such as organically raised chickens and eggs. Eating organic ... Raising backyard chickens is cleaner and more environmentally friendly than production chicken farming. ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... Set for March 6th - 8th, the 2016 meeting will be held at the ... fundamentals of nasal surgery through the most modern advancements and updates in rhinoplasty and ...
(Date:7/1/2015)... ... ... Did you know that infertility in men is more common than couples ... Center of Texas (AFCT) would like to talk about some natural ways to increase ... be a “woman’s issue,” male fertility factors can play a role in about 40% ...
(Date:7/1/2015)... ... , ... Convoy of Hope will partner with local businesses, churches, ... August 1, at Spring Lake Park High School. , During the celebration, Convoy of ... of goods and services including free food, health services, family portraits, job services, a ...
Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2
... Trial of 16 patients saw 46% improvement in symptoms ... drug -- oral EN101antisense -- reduced the severity of ... , Myasthenia gravis (MG), which affects about 20 in ... muscles. Other symptoms may include double vision, drooping eyelids, ...
... a much greater risk of finger and toe deformities, , , FRIDAY, ... new parent does is count the baby,s fingers and toes. ... unhappy surprise, because smoking increases the odds that a baby will ... half a pack a day increased the risk of having a ...
... is accumulating on how bad stress is for ... a persons risk for developing central nervous system ... other inflammatory diseases, say researchers presenting at the ... (APA). These researchers have demonstrated for the first ...
... people now diagnosed as having depression? Two experts give their ... psychiatrist from Australia says the current threshold for what is ... fears it could lead to a diagnosis of depression becoming ... be depressed and points to his own cohort study which ...
... with chronic myeloid leukemia (CML) are treated first with ... protein known to cause the cancer (BCR-ABL). If their ... to the effects of imatinib, individuals are treated with ... in a different way. However, patients that relapse after ...
... 16, 2007 One in three people exposed to ... symptoms that may require treatment, according to research published ... American Dental Association. , Researchers at Ume University, Sweden, ... dysfunction in 60 patients in hospital emergency rooms directly ...
Cached Medicine News:Health News:Another Reason Not to Smoke While Pregnant: Birth Defects 2Health News:Another Reason Not to Smoke While Pregnant: Birth Defects 3Health News:New research shows how chronic stress worsens neurodegenerative disease course 2Health News:New research shows how chronic stress worsens neurodegenerative disease course 3Health News:Are too many people diagnosed as 'depressed?' 2
... operate with either one, eight, or twelve ... an imaging process to map the entire ... individual signals can overlap). The reader from ... containing 96 parallel micro-objectives. The 96 individual ...
... combine excellent specifications and performance with convenience ... powerful performance at a price much lower ... line includes several models with options that ... OEM users, including the ability to read ...
The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits....
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
Medicine Products: